[RobinP]

Kimber what an interesting thread you have started. It is really good for us to discuss this as there really is no definitive time frame for Herceptin with various trials on-going.Having said that, I think everyone should educate themselves as much as possible about the trials out there and make their decisions accordingly on a case by case basis. Not one shoe size fits them all. Someone with stage III her2+ bc, for example, may be very inclined to do 1 or even two years of Herceptin. Then again, someone with little her2+ bc, with low risk of relapse, may be content with 1 year of herceptin.If the risk of relapse was extremely small, some may do 9 weeks of Herceptin. Somebody else with early her2+bc may decline Herceptin completely perhaps do to other standing health issues, ig a cardic history. I can't stress enough that every case is unique and deserves individual consideration.